Identification of extractable growth factors from small intestinal submucosa
暂无分享,去创建一个
S. Badylak | A. Brightman | S. Voytik-Harbin | Sherry L. Voytik‐Harbin | Andrew O. Brightman | Meredith R. Kraine | Beverly Waisner | Stephen F. Badylak | M. R. Kraine | B. Waisner
[1] A. Burgess,et al. The major colonic cell mitogen extractable from colonic mucosa is an N terminally extended form of basic fibroblast growth factor. , 1991, The Journal of biological chemistry.
[2] M J Banda,et al. Large induction of keratinocyte growth factor expression in the dermis during wound healing. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[3] R Langer,et al. Tissue engineering: biomedical applications. , 1995, Tissue engineering.
[4] Thomas A. Mustoe, MD, FACS,et al. Role of platelet‐derived growth factor in wound healing , 1991, Journal of cellular biochemistry.
[5] S. Badylak,et al. Small Intestinal Submucosa: Utilization for Repair of Rodent Abdominal Wall Defects , 1995, Annals of plastic surgery.
[6] T. A. Fritz,et al. Heparan sulfate primed on β‐D‐xylosides restores binding of basic fibroblast growth factor , 1995, Journal of cellular biochemistry.
[7] L. Bonewald,et al. Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein , 1995, The Journal of cell biology.
[8] S. Wahl,et al. Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[9] A. Yayon,et al. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis , 1994, Cell.
[10] C F Fox,et al. Prospects for application of biotechnology‐derived biomaterials , 1994, Journal of cellular biochemistry.
[11] S. Badylak,et al. Biocompatibility of small-intestinal submucosa in urinary tract as augmentation cystoplasty graft and injectable suspension. , 1994, Journal of endourology.
[12] E. Bell,et al. Strategy for the selection of scaffolds for tissue engineering. , 1995, Tissue engineering.
[13] S. Badylak,et al. Glycosaminoglycan content of small intestinal submucosa: a bioscaffold for tissue replacement. , 1996, Tissue engineering.
[14] J. Dasch,et al. Purification and characterization of transforming growth factor-beta 2.3 and -beta 1.2 heterodimers from bovine bone. , 1992, The Journal of biological chemistry.
[15] M. Klagsbrun,et al. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[16] Gregory S. Schultz,et al. EGF and TGF‐α in wound healing and repair , 1991 .
[17] K. Miyazono,et al. Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein , 1994, The Journal of cell biology.
[18] L A Geddes,et al. Small intestinal submucosa as a vascular graft: a review. , 1993, Journal of investigative surgery : the official journal of the Academy of Surgical Research.
[19] D. Moscatelli,et al. Mr 25,000 heparin-binding protein from guinea pig brain is a high molecular weight form of basic fibroblast growth factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[20] Stephen F. Badylak,et al. Small Intestinal Submucosa (SIS): A Biomaterial Conducive to Smart Tissue Remodeling , 1993 .
[21] P. Dijke,et al. Growth Factors For Wound Healing , 1989, Bio/Technology.
[22] J. Folkman,et al. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. , 1989, Biochemistry.
[23] S. Badylak,et al. Small Intestinal Submucosa as an Intra-Articular Ligamentous Graft Material: A Pilot Study in Dogs , 1994, Phlebologie.
[24] D. Rifkin,et al. Role of extracellular matrix in the action of basic fibroblast growth factor: Matrix as a source of growth factor for long‐term stimulation of plasminogen activator production and DNA synthesis , 1989, Journal of cellular physiology.
[25] T Matsumoto,et al. Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.
[26] C. Parish,et al. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: Implications for potentiation of growth factor action by heparin , 1995, Journal of cellular biochemistry.
[27] Jeffrey A. Hubbell,et al. Biomaterials in Tissue Engineering , 1995, Bio/Technology.
[28] D. Greenhalgh,et al. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. , 1990, The American journal of pathology.
[29] J. Elder,et al. Transforming growth factor alpha and epidermal growth factor levels in normal human gastrointestinal mucosa. , 1989, British Journal of Cancer.
[30] J. S. Hunt,et al. Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation. , 1995, Placenta.
[31] J. Howell. Current and future trends in wound healing. , 1992, Emergency medicine clinics of North America.
[32] M J Bissell,et al. A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. , 1995, Current opinion in cell biology.
[33] J. Lélias,et al. High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[34] L. Nanney,et al. Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin. I. Excisional wound model. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[35] E. Ruoslahti,et al. Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.
[36] I. Yannas,et al. Applications of ECM analogs in surgery , 1994, Journal of cellular biochemistry.
[37] M. Sporn,et al. Transforming Growth Factor‐β , 1990 .
[38] A. Reddi. Symbiosio of biotechnology and biomaterials: Applications in tissue engineering of bone and cartilage , 1994, Journal of cellular biochemistry.
[39] S. Badylak,et al. The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model. , 1995, Journal of biomedical materials research.